Press Releases

Home > Press Releases

Press Releases (Page 167)

Beacon Behavioral Partners Expands to Florida with the Addition of The Neuropsychiatry & TMS Group

The network of physician-driven psychiatric practices continues to expand across the Southeastern United States to enhance patient careBATON ROUGE, La., March 27, 2024 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners, a leading provider of support services for behavioral health practices, announced the acquisition of The Neuropsychiatry & TMS Group, a distinguished outpatient mental health provider in Tampa, Florida. This new alliance... ❯❯❯

Beacon Behavioral Partners Expands to Florida with the Addition of The Neuropsychiatry & TMS Group

The network of physician-driven psychiatric practices continues to expand across the Southeastern United States to enhance patient careBATON ROUGE, La., March 27, 2024 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners, a leading provider of support services for behavioral health practices, announced the acquisition of The Neuropsychiatry & TMS Group, a distinguished outpatient mental health provider in Tampa, Florida. This new alliance... ❯❯❯

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer

  The stenoparib Phase 2 monotherapy trial in advanced, recurrent ovarian cancer continues to show promise, prompting shift in resources to accelerate stenoparib development Further development of IXEMPRA® and dovitinib is de-prioritizedThe Company has been able to reduce costs materially Boston (March 27, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company... ❯❯❯

Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering

BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY)  (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $800,000,000 aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”) in a previously announced private offering exempt from the registration requirements of the Securities... ❯❯❯

LifeLabs Unveils At Home Kit Program, Empowering Ontarians to Prioritize Health with Ease

Toronto, Ontario, March 26, 2024 (GLOBE NEWSWIRE) -- LifeLabs, a leading provider of laboratory diagnostic services, is thrilled to introduce our latest offering: At-Home Self-Collection Kits.    LifeLabs’ At Home Kit Program provides a diverse range of self-collection kits for various health tests, including cervical to colorectal health, hormonal health, and blood sugar monitoring. This proactive and private solution caters to... ❯❯❯

Surgery Partners, Inc. Announces New Senior Notes Offering

BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, $600,000,000 aggregate principal amount of senior unsecured notes due 2032... ❯❯❯

To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis

RIYADH, Saudi Arabia, March 25, 2024 (GLOBE NEWSWIRE) -- In a ground-breaking development, scientists at King Faisal Specialist Hospital and Research Centre (KFSH&RC) have identified a new species of bacteria, referred to as "Stenotrophomonas Riyadhensis" through the application of whole-genome sequencing (WGS) technology. This discovery signifies a major advancement in understanding how bacteria interact with existing drugs, paving... ❯❯❯

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)

Boston (March 25, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that the Company has been granted a formal extension until April 24, 2024 to regain compliance under Nasdaq Listing Rules 5550(a)(2) (the “Bid Price Rule”) and 5550(b)(1) (the “Equity Rule”) or any of the alternative requirement... ❯❯❯

DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO

BRAIN AGE® solution is part of the CERVAI™ Brain Health AI PlatformTORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, announced its application for registration for trademark on its BRAIN AGE® brand has been approved by the Canadian Intellectual Property Office (CIPO), particularly for commercial... ❯❯❯

U.S. Oral Surgery Management Enters Maryland, Adds Five New Partner Practices in Five States

IRVING, Texas, March 19, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is finishing out Q1 2024 strong with the announcement of five new partner practices, including one in Maryland, USOSM’s first partner practice in that state. The new partners are Howard County Oral & Maxillofacial Surgery in Maryland, Blue Ridge Oral & Maxillofacial Surgery in Virginia, Collier Oral Surgery & Implant Center in Florida, Colorado... ❯❯❯